We answer some key questions about the latest new effort to kill the Affordable Care Act, including what it means for people living with HIV and what can do to make a difference.
Activist Mark Hannay explains what the bill means for people living with HIV and how it will shape the 2020 election debate.
In order to adequately address the HIV epidemic in the United States, two advocates argue that the high cost of antiretroviral drugs must be addressed.
Congress is divided, and all sorts of new possibilities are in play. What does it all mean for folks living with HIV, and for health care generally? We chatted with veteran activist Mark Hannay to find out.
Can a company be considered LGBTQ-friendly if its insurance policies ignore HIV-prevention trends?
Research indicates that robust universal health coverage could contribute to reducing HIV incidence by improving access to proven tools for reducing transmission.
It's not surprising that Trump lashed out at a black business leader, instead of violent racists, says Tim Murphy. But let's note the hypocrisy of that drug pricing jab -- and learn what we can do to actually lower drug costs.
As of July 1, United Healthcare will require prior authorization for PrEP for HIV prevention, and the use of their own mail-order pharmacy. This is complicated and confusing, says Benjamin Brooks.
Trump's early tough talk on drug pricing is now a pro-industry, anti-regulation GOP dreamscape.
The Affordable Care Act might be safe for now, but Planned Parenthood isn't -- nor are the extensive HIV prevention and testing services it provides in areas that sorely need them.